TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pfizer Anti-Infectives AB
Closing information (x1000 EUR)
Closing information | 2022/11 | 2021/11 | 2020/11 |
Turnover | 123,850 | 32,288 | 150,459 |
Financial expenses | 43 | 124 | 0 |
Earnings before taxes | 37,997 | -55,413 | 120,307 |
EBITDA | 43,458 | -49,507 | |
Total assets | 144,661 | 111,634 | 167,788 |
Current assets | 10,283 | 21,266 | 100 |
Current liabilities | 57,263 | 50,547 | 61,887 |
Equity capital | 87,398 | 61,087 | 105,901 |
- share capital | 5 | 5 | 5 |
Employees (average) | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2022/11 | 2021/11 | 2020/11 |
Solvency | 60.4% | 54.7% | 63.1% |
Turnover per employee | |||
Profit as a percentage of turnover | 30.7% | -171.6% | 80.0% |
Return on assets (ROA) | 26.3% | -49.5% | 71.7% |
Current ratio | 18.0% | 42.1% | 0.2% |
Return on equity (ROE) | 43.5% | -90.7% | 113.6% |
Change turnover | 93,601 | -117,014 | 150,459 |
Change turnover % | 309% | -78% | |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/11 | 2021/11 | 2020/11 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.